Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Pharmaceutical only | Both | Non-pharmaceutical only | Undetermined |
|---|---|---|---|---|
| Canada | 13% | 6% | 78% | 4% |
| British Columbia | 0% | 0% | 80% | 20% |
| Alberta | 5% | 0% | 90% | 5% |
| Saskatchewan | 17% | 10% | 71% | 1% |
| Manitoba | 0% | 0% | 100% | 0% |
| Ontario | 12% | 9% | 76% | 3% |
| Quebec | - | - | - | - |
| New Brunswick | 42% | 9% | 43% | 6% |
| Nova Scotia | 78% | 3% | 19% | 0% |
| Newfoundland and Labrador | 58% | - | 33% | - |
| Northwest Territories | 0% | 0% | 17% | 83% |
Download
Source
Source
Release date
March 2025
More information
Region
Canada
Survey time period
2024
Supplementary notes
Figures show apparent opioid toxicity death (AOTD): A death caused by intoxication/toxicity (poisoning) resulting from substance use, where one or more of the substances is an opioid, regardless of how it was obtained (e.g. illegally or through personal prescription). Other substances may also be involved.
Adapted from Statistics Canada, Opioid- and Stimulant-related Harms in Canada, 2023. This does not constitute an endorsement by Statistics Canada of this product.
Citation formats
